2 research outputs found
DEB TACE for Intermediate and advanced HCC – Initial Experience in a Brazilian Cancer Center
DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center
Submitted by Fábio Marques ([email protected]) on 2018-03-26T16:38:58Z
No. of bitstreams: 1
ve_Jose_Luz_etal_INI_Lapclin_2017.pdf: 987236 bytes, checksum: 583e3d9ffcded716bc24daf2d5a1dd11 (MD5)Approved for entry into archive by Raquel Dinelis ([email protected]) on 2018-04-04T13:48:38Z (GMT) No. of bitstreams: 1
ve_Jose_Luz_etal_INI_Lapclin_2017.pdf: 987236 bytes, checksum: 583e3d9ffcded716bc24daf2d5a1dd11 (MD5)Made available in DSpace on 2018-04-04T13:48:38Z (GMT). No. of bitstreams: 1
ve_Jose_Luz_etal_INI_Lapclin_2017.pdf: 987236 bytes, checksum: 583e3d9ffcded716bc24daf2d5a1dd11 (MD5)
Previous issue date: 2017Instituto Nacional de Câncer José Alencar Gomes da Silva, Departamento de Radiologia Intervencionista, Rio de Janeiro, RJ, BrasilFundação Oswaldo cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, BrasilInstituto Nacional de Câncer José Alencar Gomes da Silva, Departamento de Radiologia Intervencionista, Rio de Janeiro, RJ, BrasilInstituto Nacional de Câncer José Alencar Gomes da Silva, Departamento de Radiologia Intervencionista, Rio de Janeiro, RJ, BrasilHospital Federal de Bonsucesso. Departamento de Radiologia Intervencionista, Rio de Janeiro, RJ, BrasilHospital Federal de Bonsucesso. Departamento de Radiologia Intervencionista, Rio de Janeiro, RJ, BrasilHospital Federal de Ipanema. Departamento de Radiologia Intervencionista, Rio de Janeiro, RJ, BrasilInstituto Nacional de Câncer José Alencar Gomes da Silva, Departamento de Radiologia Intervencionista, Rio de Janeiro, RJ, BrasilUniversidade Federal de Minas Gerais. Escola de Medicina. Departamento de Anatomia e Radiologia. Minas Gerais, MG, Brasil.According to Barcelona Clinic Liver Cancer classification transarterial chemoembolization is indicated in patients with Hepatocellular Carcinoma in the intermediate stage. Drug-eluting microspheres can absorb and release the chemotherapeutic agent slowly for 14 days after its intra-arterial administration. This type of transarterial chemoembolization approach appears to provide at least equivalent effectiveness with less toxicity